摘要
核碱基代表生物活性分子(包括合成和天然产物)中的关键结构基序。 对核碱基进行的分子修饰或从天然来源中分离出来的分子修饰正在被广泛研究,以开发具有更高效力的药物,用于治疗不同疾病,如癌症,以及病毒和细菌感染。 这篇综述文章重点介绍了过去 20 年(2000-2020 年)的核碱基类似物药物发展。 讨论了核碱基及其类似物的各种药理学和药用方面。 还强调了当前的状态和限制。
关键词: 核碱基、药物发现、腺嘌呤、胸腺嘧啶、胞嘧啶、鸟嘌呤、尿嘧啶。
Current Medicinal Chemistry
Title:From Nucleic Acids to Drug Discovery: Nucleobases as Emerging Templates for Drug Candidates
Volume: 28 Issue: 34
关键词: 核碱基、药物发现、腺嘌呤、胸腺嘧啶、胞嘧啶、鸟嘌呤、尿嘧啶。
摘要: Nucleobases represent key structural motifs in biologically active molecules, including synthetic and natural products. Molecular modifications made on nucleobases or their isolation from natural sources are being widely investigated for the development of drugs with improved potency for the treatment of different diseases, such as cancer, as well as viral and bacterial infections. This review article focuses on the nucleobase analogue drug developments of the past 20 years (2000-2020). Various pharmacological and medicinal aspects of nucleobases and their analogues are discussed. The current state and limitations are also highlighted.
Export Options
About this article
Cite this article as:
From Nucleic Acids to Drug Discovery: Nucleobases as Emerging Templates for Drug Candidates, Current Medicinal Chemistry 2021; 28 (34) . https://dx.doi.org/10.2174/0929867328666210215113828
DOI https://dx.doi.org/10.2174/0929867328666210215113828 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phosphonium Salt Displays Cytotoxic Effects Against Human Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs
Current Drug Targets Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases
CNS & Neurological Disorders - Drug Targets Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward
Anti-Cancer Agents in Medicinal Chemistry Dendrimers in Therapy for Breast and Colorectal Cancer
Current Medicinal Chemistry Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism Endogenous Regulators of Adult CNS Neurogenesis
Current Pharmaceutical Design System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
Current Medicinal Chemistry Population Pharmacokinetics of Phenytoin Based on NONMEM in Patients with Intracranial Tumor During the First Week of Post-Craniotomy
Current Drug Metabolism The Bax Inhibitor-1 (BI-1) Family in Apoptosis and Tumorigenesis
Current Molecular Medicine The Role of 4-Thiazolidinone Scaffold in Targeting Variable Biomarkers and Pathways Involving Cancer
Anti-Cancer Agents in Medicinal Chemistry Current Signal Transduction Therapy for Brain Tumors Review Article
Current Signal Transduction Therapy Application of Functional Genomics to Bronchial Asthma
Current Pharmacogenomics p42.3 in Gastric Carcinoma: A Novel Biomarker and Promising Therapeutic Target
Letters in Drug Design & Discovery Cytotoxic Effects of Chemotherapeutic Drugs and Heterocyclic Compounds at Application on the Cells of Primary Culture of Neuroepithelium Tumors
Medicinal Chemistry Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy
Current Molecular Pharmacology A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma
Current Pharmaceutical Design Fiber-Optic Technologies in Laser-Based Therapeutics: Threads for a Cure
Current Pharmaceutical Biotechnology Targeting p53 in Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Small Interfering RNA for Effective Cancer Therapies
Mini-Reviews in Medicinal Chemistry